Norman Payson - 22 May 2025 Form 4 Insider Report for Progyny, Inc. (PGNY)

Role
Director
Signature
/s/ Mark Livingston, Attorney-in-Fact
Issuer symbol
PGNY
Transactions as of
22 May 2025
Transactions value $
$0
Form type
4
Filing time
27 May 2025, 21:44:01 UTC
Previous filing
28 May 2024
Next filing
18 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Payson Norman Director C/O PROGYNY, INC., 1359 BROADWAY, 2ND FLOOR, NEW YORK /s/ Mark Livingston, Attorney-in-Fact 27 May 2025 0000898544

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Award $0 +6.69K +47.64% $0.00 20.7K 22 May 2025 Direct F1
holding PGNY Common Stock 281K 22 May 2025 See footnote F2
holding PGNY Common Stock 122K 22 May 2025 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Stock Option (Right to Buy) Award $0 +30.4K $0.00 30.4K 22 May 2025 Common Stock 30.4K $20.89 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will vest on May 22, 2026, subject to the Reporting Person's continued service on such date.
F2 The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
F3 The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
F4 The shares subject to the option will vest on May 22, 2026, subject to the Reporting Person's continued service on such date.